Top

Published in:

Open Access 01-12-2021 | Magnetic Resonance Imaging | Study protocol

Hepatectomy risk assessment with functional magnetic resonance imaging (HEPARIM)

Authors: Mohamed Elsharif, Matthew Roche, Daniel Wilson, Susmita Basak, Ian Rowe, Dhakshina Vijayanand, Richard Feltbower, Darren Treanor, Lee Roberts, Ashley Guthrie, Raj Prasad, Mark S. Gilthorpe, Magdy Attia, Steven Sourbron

Published in: BMC Cancer | Issue 1/2021

Abstract

Background

Post hepatectomy liver failure (PHLF) remains a significant risk in patients undergoing curative liver resection for cancer, however currently available PHLF risk prediction investigations are not sufficiently accurate.

The Hepatectomy risk assessment with functional magnetic resonance imaging trial (HEPARIM) aims to establish if quantitative MRI biomarkers of liver function & perfusion can be used to more accurately predict PHLF risk and FLR function, measured against indocyanine green (ICG) liver function test.

Methods

HEPARIM is an observational cohort study recruiting patients undergoing liver resection of 2 segments or more, prior to surgery patients will have both Dynamic Gadoxetate-enhanced (DGE) liver MRI and ICG testing.

Day one post op ICG testing is repeated and R15 compared to the Gadoxetate Clearance (GC) of the future liver remnant (FLR-GC) as measure by preoperative DGE- MRI which is the primary outcome, and preoperative ICG R15 compared to GC of whole liver (WL-GC) as a secondary outcome.

Data will be collected from medical records, biochemistry, pathology and radiology reports and used in a multi-variate analysis to the value of functional MRI and derive multivariant prediction models for future validation.

Discussion

If successful, this test will potentially provide an efficient means to quantitatively assess FLR function and PHLF risk enabling surgeons to push boundaries of liver surgery further while maintaining safe practice and thereby offering chance of cure to patients who would previously been deemed inoperable. MRI has the added benefit of already being part of the routine diagnostic pathway and as such would have limited additional burden on patients time or cost to health care systems. (Hepatectomy Risk Assessment With Functional Magnetic Resonance Imaging - Full Text View - ClinicalTrials.gov, n.d.)

Trial registration

ClinicalTrials.gov, ClinicalTrials.gov NCT04705194 - Registered 12th January 2021 – Retrospectively registered

Available only for authorised users

Ismaili, N. (2011). Treatment of colorectal liver metastases. World J Surg Oncol https://doi.org/https://doi.org/10.1186/1477-7819-9-154, 9, 1.

Jegatheeswaran, S., Mason, J. M., Hancock, H. C., & Siriwardena, A. K. (2013). The liver-first approach to the management of colorectal cancer with synchronous hepatic metastases: a systematic review. JAMA Surg https://doi.org/https://doi.org/10.1001/jamasurg.2013.1216, 148, 4, 385, 391.

Sheth, K. R., & Clary, B. M. (2005). Management of hepatic metastases from colorectal cancer. Clin Colon Rectal Surg https://doi.org/https://doi.org/10.1055/s-2005-916282, 18, 03, 215, 223.

Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor A. Bray, F. (2019). Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer, 144(8), 1941–1953. https://doi.org/https://doi.org/10.1002/ijc.31937.

Kauffmann, R., & Fong, Y. (2014). Post-hepatectomy liver failure, 3(5), 238–246. https://doi.org/https://doi.org/10.3978/j.issn.2304-3881.2014.09.01.

Jaeck, D., Bachellier, P., Oussoultzoglou, E., Weber, J.-C., & Wolf, P. (2004). Surgical resection of hepatocellular carcinoma. Post-operative outcome and long-term results in Europe: An overview. Liver Transplantation. https://doi.org/https://doi.org/10.1002/lt.20041.

Paugam-Burtz, C., Janny, S., Delefosse, D., Dahmani, S., Dondero, F., Mantz, J., & Belghiti, J. (2009). Prospective validation of the “fifty-fifty” criteria as an early and accurate predictor of death after liver resection in intensive care unit patients. Ann Surg https://doi.org/https://doi.org/10.1097/SLA.0b013e31819279cd, 249, 1, 124, 128.

Ren, Z., Xu, Y., & Zhu, S. (2012). Indocyanine green retention test avoiding liver failure after hepatectomy for hepatolithiasis. Hepatogastroenterology. https://doi.org/https://doi.org/10.5754/hge11453.

Reissfelder, C., Rahbari, N. N., Koch, M., Kofler, B., Sutedja, N., Elbers, H., Büchler M. W. Weitz, J. (2011). Postoperative course and clinical significance of biochemical blood tests following hepatic resection. Br J Surg https://doi.org/https://doi.org/10.1002/bjs.7459, 98, 6, 836, 844.

10.

Blüthner, E., Jara, M., Shrestha, R., Faber, W., Pratschke, J., Stockmann, M., & Malinowski, M. (2019). The predictive value of future liver remnant function after liver resection for HCC in noncirrhotic and cirrhotic patients. HPB. https://doi.org/https://doi.org/10.1016/j.hpb.2018.11.012, 21, 7, 912, 922.

11.

Yokoyama, Y., Nishio, H., Ebata, T., Igami, T., Sugawara, G., & Nagino, M. (2010). Value of indocyanine green clearance of the future liver remnant in predicting outcome after resection for biliary cancer. Br J Surg https://doi.org/https://doi.org/10.1002/bjs.7084, 97, 8, 1260, 1268.

12.

Yokoyama, Yukihiro, Ebata, T., Igami, T., Sugawara, G., Mizuno, T., Yamaguchi, J., & Nagino, M. (2016). The predictive value of Indocyanine green clearance in future liver remnant for Posthepatectomy liver failure following hepatectomy with extrahepatic bile duct resection. World J Surg https://doi.org/https://doi.org/10.1007/s00268-016-3441-1, 40, 6, 1440, 1447.

13.

Cieslak, K. P., Bennink, R. J., de Graaf, W., van Lienden, K. P., Besselink, M. G., Busch, O. R. C., Gouma D. J. van Gulik, T. M. (2016). Measurement of liver function using hepatobiliary scintigraphy improves risk assessment in patients undergoing major liver resection. HPB. https://doi.org/https://doi.org/10.1016/j.hpb.2016.06.006, 18, 9, 773, 780.

14.

Cieslak, K. P., Huisman, F., Bais, T., Bennink, R. J., van Lienden, K. P., Verheij, J., Besselink M. G., Busch O. R.C. van Gulik, T. M. (2017). Future remnant liver function as predictive factor for the hypertrophy response after portal vein embolization. Surgery (United States) https://doi.org/https://doi.org/10.1016/j.surg.2016.12.031, 162, 1, 37, 47.

15.

De Graaf, W., Van Lienden, K. P., Van Gulik, T. M., & Bennink, R. J. (2010). 99mTc-mebrofenin hepatobiliary scintigraphy with SPECT for the assessment of hepatic function and liver functional volume before partial hepatectomy. J Nucl Med https://doi.org/https://doi.org/10.2967/jnumed.109.069724, 51, 2, 229, 236.

16.

Tomassini, F., Giglio, M. C., De Simone, G., Montalti, R., & Troisi, R. I. (2020). Hepatic function assessment to predict post-hepatectomy liver failure: what can we trust? A systematic review Updates Surg https://doi.org/https://doi.org/10.1007/s13304-020-00859-7, 72, 4, 925, 938.

17.

Sourbron, S., Sommer, W. H., Reiser, M. F., & Zech, C. J. (2012). Combined quantification of liver perfusion and function with dynamic gadoxetic acid-enhanced MR imaging. Radiology. https://doi.org/https://doi.org/10.1148/radiol.12110337, 263, 3, 874, 883.

18.

Kim, D. K., Choi, J. Il, Choi, M. H., Park, M. Y., Lee, Y. J., Rha, S. E., & Jung, S. E. (2018). Prediction of posthepatectomy liver failure: MRI with hepatocyte-specific contrast agent versus indocyanine green clearance test. Am J Roentgenol https://doi.org/https://doi.org/10.2214/AJR.17.19206, 211, 3, 580, 587.

19.

Yamada, S., Shimada, M., Morine, Y., Imura, S., Ikemoto, T., Saito, Y., Takasu C., Yoshikawa M., Teraoku H. Yoshimoto, T. (2019). A new formula to calculate the resection limit in hepatectomy based on Gd-EOB-DTPA-enhanced magnetic resonance imaging. PLoS One https://doi.org/https://doi.org/10.1371/journal.pone.0210579, 14, 1, e0210579.

20.

Yoon, J. H., Choi, J. Il, Jeong, Y. Y., Schenk, A., Chen, L., Laue, H., Kim S. Y. Lee, J. M. (2016). Pre-treatment estimation of future remnant liver function using gadoxetic acid MRI in patients with HCC. J Hepatol https://doi.org/https://doi.org/10.1016/j.jhep.2016.07.024, 65, 6, 1155, 1162.

21.

Nilsson, H., Karlgren, S., Blomqvist, L., & Jonas, E. (2015). The inhomogeneous distribution of liver function: possible impact on the prediction of post-operative remnant liver function. HPB. https://doi.org/https://doi.org/10.1111/hpb.12348, 17, 3, 272, 277.

22.

Longbotham, D., Wilson, D., Rowe, I., Vijayanand, D., Attia, M., Guthrie, A., … Sourbron, S. (2019). Prediction of post-hepatectomy liver function with dynamic Gadoxetate-enhanced MRI. In International Society of Magnetic Resonance in medicine (p. 4738).

Title: Hepatectomy risk assessment with functional magnetic resonance imaging (HEPARIM)
Authors: Mohamed Elsharif
Matthew Roche
Daniel Wilson
Susmita Basak
Ian Rowe
Dhakshina Vijayanand
Richard Feltbower
Darren Treanor
Lee Roberts
Ashley Guthrie
Raj Prasad
Mark S. Gilthorpe
Magdy Attia
Steven Sourbron
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Magnetic Resonance Imaging
Magnetic Resonance Imaging
Liver Resection
Liver Resection
Published in: BMC Cancer / Issue 1/2021
Electronic ISSN: 1471-2407
DOI: https://doi.org/10.1186/s12885-021-08830-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Discussion

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2021

IQGAP2 acts as an independent prognostic factor and is related to immunosuppression in DLBCL

The identification of gene signatures in patients with extranodal NK/T-cell lymphoma from a pair of twins

A systematic review and meta-analysis of nab-paclitaxel mono-chemotherapy for metastatic breast cancer

Clinical outcomes observation in stage IIB–IIIB cervical cancer treated by adjuvant surgery following concurrent chemoradiotherapy

Post-treatment work patterns amongst survivors of lymphoma treated with high-dose chemotherapy with autologous stem-cell transplantation

Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers

Keynote webinar | Spotlight on antibody–drug conjugates in cancer